Since the first successful application of extracorporeal membrane oxygenation (ECMO) in 1972, ECMO’s role in the management of respiratory and circulatory collapse continues to be refined and debated. Randomized clinical trials aimed at establishing efficacy and patient selection criteria have been fraught with ethical challenges. Growing concerns over rising health care costs require that careful evaluations of cost, utilization, and ethical issues surrounding heroic life-saving interventions such as ECMO are undertaken. Continued analyses of ECMO’s place in the medical management of respiratory and circulatory failure will help ensure that ECMO is used for not only prolonging life but also for providing a chance for “quality of life” following recovery from near-fatal illnesses.
Lewandowski K.Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care. 2000 ;4: 156-168.
2.
Wolfson P.The development and use of extracorporeal membrane oxygenation in neonates . Ann Thorac Surg. 2003;76:S2224-S2229.
3.
Hemmila MR, Rowe SA, Boules TN, et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg. 2004;240:595-607.
4.
Conrad S., Rycus P., Dalton H.Extracorporeal Life Support Registry Report 2004. ASAIO J . 2005; 51:4-10.
5.
Shanley C., Hirschl RB, Schumacher RE, et al. Extracorporeal life support for neonatal respiratory failure a 20-year experience. Ann Surg. 1994;220:269-282.
6.
Extracorporeal Life Support Organization.ECMO Registry of the Extracorporeal Life Support Organization (ELSO). Ann Arbor, MI: ELSO; 2009.
7.
Schuerer DJ, Kolovos NS, Boyd KV, Coopersmith CMExtracorporeal membrane oxygenation: current clinical practice, coding, and reimbursement. Chest. 2008;134: 179-184.
8.
Morris M., Ittenbach R., Godinez R., et al. Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation. Crit Care Med. 2004;32:1061-1069.
9.
Thalanany M. , Mugford M., Hibbert C., et al; CESAR Trial Group.Methods of data collection and analysis for the economic evaluation alongside a national, multi-centre trial in the UK: conventional ventilation or ECMO for severe adult respiratory failure (CESAR). BMC Health Serv Res. 2008;8:94.
10.
Peek G., Clemens F., Elbourne D., et al. CESAR: conventional ventilatory support vs extracorporeal membrane oxygenation for severe adult respiratory failure. BMC Health Serv Res. 2006;6:163.
11.
Schumacher R., Roloff D., Chapman R., Snedecor S., Bartlett RHExtracorporeal membrane oxygenation in term newborns: a prospective cost-benefit analysis. ASAIO J. 1993;39:873-879.
12.
Roberts TEEconomic evaluation and randomized controlled trial of extracorporeal membrane oxygenation: UK collaborative trial. The Extracorporeal Membrane Oxygenation Economics Working Group. BMJ. 1998; 317:911-916.
13.
Petrou S., Bischof M., Bennett C., Elbourne D., Field D., McNally H.Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial. Pediatrics. 2006;117:1640-1649.
14.
Van Litsenburg R., De Mos N., Edgell D., Gruenwald C., Bohn DJ, Parshuram CSResource use and health outcomes of paediatric extracorporeal membrane oxygenation. Arch Dis Child Fetal Neonatal Ed. 2005;90: F176-F177.
15.
Vats A., Pettignano R., Culler S., Wright J.Cost of extracorporeal life support in pediatric patients with acute respiratory failure. Crit Care Med. 1998;26:1587-1592.
16.
Ayad O., Dietrich A., Mihalov L.Extracorporeal membrane oxygenation. Emerg Med Clin North Am. 2008;26: 953-959.
17.
Stevens A., Colin-Jones D., Gabbay J.Quick and clean: authoritative health technology assessment for local health care contracting. Health Trends. 1995;27:37-42.
18.
Mugford M., Elbourne D., Field D.Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants. Cochrane Database Syst Rev. 2007;(4) CD001340. doi:10.1002/14651858.CD001340.pub2.
19.
Bartlett RH , Roloff DW, Custer JR, Younger JG, Hirschl RBExtracorporeal life support: the University of Michigan experience. JAMA. 2000;283:904-908.
20.
Heyland DK, Konopad E., Noseworthy TW, Johnston R., Gafni A.Is it ‘worthwhile’ to continue treating patients with a prolonged stay (>14 days) in the ICU? An economic evaluation. Chest. 1998;114:192-198.
21.
Sznajder M, Aegerter P, Launois R, Merliere Y, Guidet B, CubRea. A cost-effectiveness analysis of stays in intensive care units. Intensive Care Med. 2001;27:146-153. 22. King J. Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. J Neurosurg. 1995;83:403-412.
22.
Sisk JE, Moskowitz AJ, Whang W., et al. Cost effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA. 1997;278:1333-1339.
23.
The U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients UNOS; Arbor Research Collaborative for Health 2007 OPTN/SRTR Annual Report: Transplant Data 1997-2006.
24.
Schmidt CD, Elliott CG, Carmelli D., et al. Prolonged mechanical ventilation for respiratory failure: a cost-benefit analysis. Crit Care Med. 1983 ;11:407-411.
25.
Mugford M.The cost of neonatal care: reviewing the evidence. Soc Prev Med. 1995;40:361-368.
26.
Bartlett RH , Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JBExtracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics. 1985;76:479-487.
27.
Toomasian JM , Snedecor SM, Cornell RG, et al. National experience with extracorporeal membrane oxygenation for newborn respiratory failure. Data from 715 cases . ASAIO Trans. 1988;34:140-147.
28.
Bartlett RH , Andrews AF, Toomasian JM, Haiduc NJ, Gazzaniga ABExtracorporeal membrane oxygenation (ECMO) for newborn respiratory failure: forty-five cases. Surgery . 1982;92:425-433.
29.
O’Rourke PP, Crone R., Vacanti J.Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics. 1989;84:957-963.
30.
UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet. 1996;348:75-82.
31.
Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. http://www.wmw.et/e/policy/b3.htm . Accessed July 4, 2009.
